End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

20258 citationsJournal Articlegreen Open Access

Authors

Andrea Necchi · Vita-Salute San Raffaele University

Matthew D. Galsky · Icahn School of Medicine at Mount Sinai

Nazlı Dizman · The University of Texas MD Anderson Cancer Center

David H. Aggen · Memorial Sloan Kettering Cancer Center

Neeraj Agarwal · University of Utah

Hikmat Al‐Ahmadie · Memorial Sloan Kettering Cancer Center

Andrea B. Apolo

Abstract

The consensus definition of cCR and the framework presented in this study can serve as a foundation for thorough testing of risk-adapted bladder-sparing treatment paradigms for MIBC.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Urological Disorders and Treatments

Publication Details

Published in: Journal of Clinical Oncology

Volume 43, Issue 32, pp. 3536-3544

DOI: 10.1200/jco-25-01608

Field-Weighted Citation Impact: 16.08

Command Palette

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

Authors

Abstract

Topics & Keywords

Publication Details